Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
100
days
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study
AuthorsAlessandro Rizzo; Fernando Sabino Marques Monteiro; Veronica Mollica; Oronzo Brunetti; Elsa Vitale; Angela Monica Sciacovelli; Andrey Soares; Francesco Massari; Matteo Santoni
Affiliations1. S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy; 2. Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; 3. Oncology and Hematology Department, Hospital Sírio-Libanês, Brasilia, Brazil; 4. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Scientific Directorate, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy; 6. Hospital Israelita Albert Einstein, São Paulo, Brazil; 7. Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; 8. Oncology Unit, Macerata Hospital, Macerata, Italy
157
days
Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment
AuthorsXianglin Hu; Huajian Wu; Kewen Hu; Yani Kang; Guoqiang Hua; Mo Cheng; Wangjun Yan; Wending Huang
Affiliations1. Department of Musculoskeletal Oncology, Spine Tumor Center, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen, China; 4. Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China; 5. Research and Early Development (RED) of D1 Medical Technology Company, Shanghai, China
339
days
Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells
AuthorsKimberly J. Jasmer; Vinit C. Shanbhag; Kevin Muñoz Forti; Lucas T. Woods; Nikita S. Gudekar; Gary A. Weisman; Michael J. Petris
Affiliations1. Christopher S. Bond Life Sciences Center 540F, University of Missouri, Columbia, USA; 2. Department of Biochemistry, University of Missouri, Columbia, USA; 3. Department of Ophthalmology, University of Missouri, Columbia, USA
90
days
Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study
AuthorsAlexander Fabian; Daniel Buergy; Fabian Weykamp; Juliane Hörner-Rieber; Denise Bernhardt; Judit Boda-Heggemann; Montserrat Pazos; Nora Mehrhof; David Kaul; Alicia S. Bicu; Eugenia Vlaskou Badra; Susanne Rogers; Stefan Janssen; Hossein Hemmatazad; Katharina Hintelmann; Eleni Gkika; Tim Lange; Konstantinos Ferentinos; Heiko Karle; Thomas Brunner; Andrea Wittig; Marciana Nona-Duma; Oliver Blanck; David Krug
Affiliations1. Department of Radiation Oncology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; 2. Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany; 3. Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; 4. Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 5. Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; 6. National Center for Tumor Diseases (NCT), Heidelberg, Germany; 7. Department of Radiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany; 8. Department of Radiation Oncology, Technical University of Munich, Munich, Germany; 9. Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany; 10. Department of Radiation Oncology, Charité—Universitätsmedizin Berlin, Berlin, Germany; 11. Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany; 12. Department of Radiation Oncology, University Hospital & University of Zurich, Zurich, Switzerland; 13. Radiation Oncology Center KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland; 14. Department of Radiation Oncology, University of Lubeck, Lubeck, Germany; 15. Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany; 16. Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 17. Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 18. Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany; 19. Department of Radiation Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany; 20. Clinic for Radiotherapy, Hannover Medical School, Hannover, Germany; 21. Department of Radiation Oncology, German Oncology Center, European University of Cyprus, Limassol, Cyprus; 22. Department of Radiation Oncology and Radiotherapy, University Medical Center, Mainz, Germany; 23. Department of Radiation Oncology, University Hospital Graz, Graz, Austria; 24. Department of Radiation Oncology, University Hospital Würzburg, Würzburg, Germany; 25. Department of Radiation Oncology, HELIOS Hospital Schwerin, Schwerin, Germany; 26. Department for Human Medicine, MSH Medical School Hamburg, Hamburg, Germany
127
days
Current preclinical models of brain metastasis
AuthorsZacharie Drouin; Flavie Lévesque; Korina Mouzakitis; Marilyne Labrie
Affiliations1. Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada; 2. Centre de Recherche du Centre Hospitalier de l’Université de Sherbrooke (CRCHUS), Sherbrooke, Canada; 3. Institut de Recherche sur le Cancer de l’Université de Sherbrooke (IRCUS), Sherbrooke, Canada
55
days
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy
AuthorsD. Caivano; D. Pezzulla; P. Bonome; C. Ricciardi; P. Zuccoli; M. Rotondi; R. C. Sigillo; M. Serio; F. Giannetti; A. Molinari; C. Menichelli; M. Valeriani; V. De Sanctis; A. Fanelli; M. F. Osti
Affiliations1. Traslational Medicine and Oncology, Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psycology, Sapienza University of Rome, Rome, Italy; 2. Radiation Oncology Unit, Responsible Research Hospital, Campobasso, Italy; 3. Department of Radiation Oncology, Sant’ Andrea Hospital, Sapienza University of Rome, Rome, Italy; 4. Istituto di Ricerche Cliniche Ecomedica (Ergea Group), Empoli, Firenze, Italy; 5. Department of Radiotherapy, University Hospital of Trieste, Trieste, Italy; 6. MultiMedica IRCCS Sesto San Giovanni Radiotherapy Service, Milano, Italy
74
days
Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: a retrospective comparison with metastasectomy
AuthorsYoungju Song; Yeon Joo Kim; Sehoon Choi; Jae Kwang Yun; Jin-Hee Ahn; Jeong Eun Kim; Jong Seok Lee; Wanlim Kim; Kyung-Hyun Do; Hye Won Chung; Geun Dong Lee; Si Yeol Song
Affiliations1. Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 2. Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 3. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 4. Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; 5. Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
90
days
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis
AuthorsAlessandro Rizzo; Fernando Sabino Marques Monteiro; Veronica Mollica; Andrey Soares; Oronzo Brunetti; Angela Dalia Ricci; Francesco Massari; Matteo Santoni
Affiliations1. S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy; 2. Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil; 3. Oncology and Hematology Department, Hospital Sírio-Libanês, Brasilia, Brazil; 4. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Hospital Israelita Albert Einstein, São Paulo, Brazil; 6. Medical Oncology Unit, National Institute of Gastroenterology, IRCCS “S. de Bellis” Research Hospital, Castellana Grotte, Italy; 7. Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy; 8. Oncology Unit, Macerata Hospital, Macerata, Italy
64
days
Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interface
AuthorsEmily Latacz; Sanne M. L. Verheul; Yasmine Sillis; Pieter-Jan van Dam; Michail Doukas; Dirk J. Grunhagen; Hanna Nyström; Piet Dirix; Luc Dirix; Steven Van Laere; Cornelis Verhoef; Peter Vermeulen
Affiliations1. Translational Cancer Research Unit, Ziekenhuis aan de Stroom (ZAS), Antwerp, Belgium; 2. Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium; 3. Department of Gastrointestinal Surgery and Surgical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 4. Data Science, CellCarta NV, Antwerp, Belgium; 5. Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 6. Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden
73
days
Disrupting CENP-N mediated SEPT9 methylation as a strategy to inhibit aerobic glycolysis and liver metastasis in colorectal cancer
AuthorsJunge Bai; Zhexue Wang; Ming Yang; Jun Xiang; Zheng Liu
Affiliations1. Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2. Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days